Year: 1998
Type: review
Abstract: HILE NO ONE WOULD DENY that there has been great progress made in our understanding of metabolic bone disease and our ability to evaluate these disorders in affected subjects, the accompanying editorial by Dr. Michael Parfitt provides undeniable evidence that we must recognize that progress has mixed benefits.Indeed, he points out what we have lost by reducing the use of bone biopsy and standard radiographies while relying on dual-energy X-ray absorptiometry of the central skeleton.His insights are extraordinarily relevant to the clinical decision making in patients with the bone abnormalities typically encountered in chronic renal failure.Clearly this article is essential reading for nephrologists, endocrinologists, rheumatologists, orthopedists, and bone basic scientists.Moreover, insights provided are a tribute to the gifted perspective that Dr. Parfitt brings to the bone and mineral community.
Author: A. Michael Parfitt
Institution: University of Arkansas for Medical Sciences
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2124967376
